← Leaderboards
Joseph B Shrager
Veterans Admin Palo Alto Health Care Sys
$2,276,071
Attributed
$3,249,222
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $667.9K · FY2013–25$1M$750K$500K$250K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,249,222 · 3
VA$0 · 1
By mechanism
R01$1,946,303 · 1
U54$928,715 · 1
R21$374,204 · 1
I01$0 · 1
Top collaborators
- Leah M Backhus9 shared
Most similar at Veterans Admin Palo Alto Health Care Sys
Same institution · by research overlap
- Leah M Backhus$973,152
Others in their field
Top investigators on “Cessation Of Life”
- David R. Weir · University Of Michigan At Ann Arbor$345,522,974
- John M Lachin · George Washington University$134,302,892
- David M Nathan · Massachusetts Institute Of Technology$127,791,564
- Judith S Hochman · New York University School Of Medicine$112,898,313
- Jeffrey H Samet · Boston University Medical Campus$91,739,367
- Judith S. Currier · University Of California Los Angeles$85,330,415
Research focus
Cessation Of LifeAtrophicPathway InteractionsAnimalsPharmaceutical PreparationsBreathingPreventMuscleLeadIntensive Care UnitsMolecularBaseApoptosisFunctional DisorderFiberRattusClinical TrialsVentilatorAutophagocytosisHourMitochondriaProteolysisMechanical VentilationOxidative Stress
Grant awards (17)
Biospecimen and Data Core$309,126
U54 · FY2025 · CA · contact PI
Investigation of the Functional Roles of MicroRNA-320 in Skeletal Muscle$374,204
R21 · FY2024 · AR · contact PI
Biospecimen and Data Core$293,669
U54 · FY2024 · CA · contact PI
Biospecimen and Data Core$325,920
U54 · FY2023 · CA · contact PI
A Mechanistic Clinical Trial of JAK Inhibition to Prevent Ventilator-induced Diaphragm Dysfunction$391,250
R01 · FY2022 · HL · contact PI
A Mechanistic Clinical Trial of JAK Inhibition to Prevent Ventilator-induced Diaphragm Dysfunction$113,221
R01 · FY2022 · HL · contact PI
A Mechanistic Clinical Trial of JAK Inhibition to Prevent Ventilator-induced Diaphragm Dysfunction$9,609
R01 · FY2022 · HL · contact PI
A Mechanistic Clinical Trial of JAK Inhibition to Prevent Ventilator-induced Diaphragm Dysfunction$391,250
R01 · FY2021 · HL · contact PI
A Mechanistic Clinical Trial of JAK Inhibition to Prevent Ventilator-induced Diaphragm Dysfunction$115,357
R01 · FY2021 · HL · contact PI
A Mechanistic Clinical Trial of JAK Inhibition to Prevent Ventilator-induced Diaphragm Dysfunction$104,609
R01 · FY2021 · HL · contact PI
A Mechanistic Clinical Trial of JAK Inhibition to Prevent Ventilator-induced Diaphragm Dysfunction$38,507
R01 · FY2021 · HL · contact PI
A Mechanistic Clinical Trial of JAK Inhibition to Prevent Ventilator-induced Diaphragm Dysfunction$391,250
R01 · FY2020 · HL · contact PI
A Mechanistic Clinical Trial of JAK Inhibition to Prevent Ventilator-induced Diaphragm Dysfunction$391,250
R01 · FY2019 · HL · contact PI
Preclinical Therapy and Novel Mechanisms in Ventilator-induced Diaphragm Atrophy$0
I01 · FY2016 · VA · contact PI
Preclinical Therapy and Novel Mechanisms in Ventilator-induced Diaphragm Atrophy$0
I01 · FY2015 · VA · contact PI
Preclinical Therapy and Novel Mechanisms in Ventilator-induced Diaphragm Atrophy$0
I01 · FY2014 · VA · contact PI
Preclinical Therapy and Novel Mechanisms in Ventilator-induced Diaphragm Atrophy$0
I01 · FY2013 · VA · contact PI